uspto-grants-1991_03 · 10.6084/m9.figshare.5104873.v1 · US05002960
查看IDENTITY
结构与身份
- 标准SMILES
- Cc1cc(CCCCCCCOc2ccc(C3=NCCO3)cc2)on1
- InChIKey
- FKLJPTJMIBLJAV-UHFFFAOYSA-N
- 分子式
- C20H26N2O3
- 平均分子量
- 342.4 g/mol
- 单同位素质量
- 342.1943427
COMPUTED
结构计算性质
- XLogP
- 4.4
- 极性表面积
- 56.9 Ų
- 氢键供体
- 0
- 氢键受体
- 5
- 可旋转键
- 10
- 重原子
- 25
- 形式电荷
- 0
- 复杂度
- 408
PHARMACOLOGY
药理信息
MeSH Pharmacological Classification
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
ALIASES
名称与别名
REACTIONS
参与反应
uspto-grants-1991_03 · 10.6084/m9.figshare.5104873.v1 · US05002960
查看uspto-grants-1991_03 · 10.6084/m9.figshare.5104873.v1 · US05002960
查看Training data from https://doi.org/10.1039/C8SC04228D (3/10) · 10.1039/C8SC04228D
查看Training data from https://doi.org/10.1039/C8SC04228D (5/10) · 10.1039/C8SC04228D
查看uspto-grants-1989_06 · 10.6084/m9.figshare.5104873.v1 · US04843087
查看uspto-grants-1989_06 · 10.6084/m9.figshare.5104873.v1 · US04843087
查看uspto-grants-1989_06 · 10.6084/m9.figshare.5104873.v1 · US04843087
查看